United States Interventional Cardiology Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Interventional Cardiology Market reached US$ 14.47 billion in 2023 and is expected to reach US$ 28.67 billion by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/interventional-cardiology-market?sb

Key Development:

United States: Recent Interventional Cardiology Developments

✅ In December 2025, the U.S. FDA scheduled a Circulatory System Devices Panel review for the V-Wave Ventura Interatrial Shunt System, a permanent implant designed to improve symptoms in patients with advanced chronic heart failure. The review marks a critical regulatory milestone ahead of potential market authorization. It reflects growing innovation in minimally invasive heart failure interventions.

✅ In November 2025, FDA granted approval to restart the NobleStitch EL PFO closure clinical trial, enabling renewed enrollment for its suture-mediated, non-implant closure technology. The device targets patients with patent foramen ovale to reduce recurrent cryptogenic stroke risk. This decision reactivates clinical momentum for non-metallic closure solutions.

✅ In October 2025, Terumo received U.S. FDA 510(k) clearance for its OPUSWAVE® dual intravascular imaging platform and DualView® catheter, combining two imaging modalities in a single system. The launch supports enhanced visualization during PCI and complex coronary interventions. It strengthens imaging-guided interventional workflows.

✅ In October 2025, Orchestra BioMed secured amended IDE approval from the FDA to initiate a pivotal trial for its Virtue® Sirolimus AngioInfusion Balloon. The trial will compare the novel sirolimus delivery method against existing drug-coated balloons. It advances next-generation coronary drug-delivery technologies.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=interventional-cardiology-market

Japan: Recent Interventional Cardiology Developments

✅ In November 2025, Japanese interventional cardiology programs advanced the clinical adoption of next-generation coronary stents and catheter-based occlusion devices, emphasizing reduced invasiveness and procedural efficiency. These developments support improved outcomes in complex coronary interventions. Domestic innovation continues to gain momentum across hospital networks.

✅ In October 2025, Abbott expanded the availability of its next-generation drug-eluting stent platform in Japan, targeting complex coronary artery disease cases. The launch focuses on enhanced deliverability and long-term vessel healing. It reinforces competition in Japan's advanced coronary device segment.

✅ In September 2025, Boston Scientific entered a strategic collaboration with a leading Japanese healthcare provider to co-develop catheter-based heart valve repair technologies. The partnership aims to accelerate localized innovation and clinical validation. It strengthens Japan's role in transcatheter structural heart solutions.

✅ In August 2025, Terumo Corporation announced expanded manufacturing capacity in Japan dedicated to interventional cardiology devices, including catheters and access systems. The investment supports rising procedural demand and supply chain resilience. It underlines Japan's growing domestic production capability in cardiovascular devices.

Key Players:

=> Abbott, Boston Scientific Corporation, Johnson & Johnson, Medtronic, B.Barun Melsungen, Biosensors International Ltd., Terumo Corporation, Biotronik SE and Co. KG, Edwards Lifesciences Corporation and Cook Medical Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/interventional-cardiology-market?sb

Key Segments:

By Type
Stents - ~38% share

Bare-Metal Stents

Drug-Eluting Stents

Bio-absorbable Stents
Drug-eluting stents dominate this segment due to lower restenosis rates and improved long-term outcomes.

Catheters - ~25% share

Angioplasty Catheters

Guiding Catheters

Pulmonary Artery Catheters

IVUS Catheters
High utilization in diagnostic and interventional cardiovascular procedures supports steady growth.

PTCA Balloons - ~18% share

Normal Balloons

Cutting Balloons

Scoring Balloons

Drug-Eluting Balloons
Drug-eluting and specialty balloons are gaining traction for complex coronary lesions.

Imaging Systems - ~12% share

Intravascular Ultrasound (IVUS)

Fractional Flow Reserve (FFR)

Optical Coherence Tomography (OCT)
Rising adoption driven by demand for precision-guided interventions.

Laser Procedures - ~4% share

Utilized in complex lesion modification and chronic total occlusion treatments.

Atherectomy Devices - ~2% share

Growth supported by increasing peripheral and coronary artery disease cases.

Others - ~1% share

Includes emerging and adjunct interventional devices.

By End-User
Hospitals - ~65% share

Primary centers for complex cardiovascular interventions with advanced imaging and surgical infrastructure.

Ambulatory Surgical Centres - ~20% share

Growing adoption due to minimally invasive procedures and cost-effective care models.

Physicians' Offices - ~15% share

Increasing role in diagnostic and follow-up interventional procedures.

FAQ

What is the current size of the Interventional Cardiology Market?

A: In 2023, the Interventional Cardiology Market was valued at US$ 14.47 billion , reflecting its strong industry presence.

Q2: How large is the Interventional Cardiology Market expected to be by 2031?

A: By 2031, industry forecasts suggest the Interventional Cardiology Market will grow to around US$ 28.67 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Interventional Cardiology Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 9.1% during the forecast period from 2024 to 2031.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.